Form 4: Aurinia COO Donley Sells Shares for Tax Obligations

Aurinia Pharmaceuticals' Chief Operating Officer, Matthew Maxwell Donley, disposed of 32,901 common shares to cover tax withholding obligations.

Summary

• Matthew Maxwell Donley, Chief Operating Officer of Aurinia Pharmaceuticals Inc. (AUPH), reported a transaction.
• On February 20, 2026, Donley disposed of 32,901 shares of common stock.
• The disposition was made at a price of $14.4 per share.
• This transaction represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units.
• Following this transaction, Donley beneficially owns 662,900 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It reports a routine, non-discretionary transaction related to executive compensation and tax obligations, with no direct positive or negative implications for the company's operational or financial performance.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those involving the disposition of shares to cover tax withholding obligations upon the vesting of restricted stock units, are common and generally considered routine administrative events. Such transactions typically do not reflect a discretionary decision by the insider to sell shares based on their view of the company's future prospects, nor do they usually indicate a shift in broader industry trends.

Key Dates

Recommendation

The transaction reported is a routine disposition of shares to cover tax liabilities associated with the vesting of restricted stock units. It does not reflect a discretionary sale by the insider based on company performance or outlook, and therefore, does not provide new information that would warrant a change in investment recommendation. A 'hold' recommendation is appropriate as this event is neutral to the company's fundamentals.

Keywords

Aurinia Pharmaceuticals, AUPH, Insider Transaction, Form 4, Matthew Donley, COO, Stock Sale, Tax Withholding, Restricted Stock Units